- Home
- PLRX vs JVSA Comparison
PLRX vs JVSA Comparison
Compare PLRX & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- JVSA
- Stock Information
- Founded
- PLRX 2015
- JVSA 2021
- Country
- PLRX United States
- JVSA Hong Kong
- Employees
- PLRX N/A
- JVSA N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- JVSA
- Sector
- PLRX Health Care
- JVSA
- Exchange
- PLRX Nasdaq
- JVSA NYSE
- Market Cap
- PLRX 90.9M
- JVSA 82.7M
- IPO Year
- PLRX 2020
- JVSA 2024
- Fundamental
- Price
- PLRX $1.44
- JVSA $10.79
- Analyst Decision
- PLRX Hold
- JVSA
- Analyst Count
- PLRX 10
- JVSA 0
- Target Price
- PLRX $9.79
- JVSA N/A
- AVG Volume (30 Days)
- PLRX 744.6K
- JVSA 29.4K
- Earning Date
- PLRX 05-20-2025
- JVSA 01-01-0001
- Dividend Yield
- PLRX N/A
- JVSA N/A
- EPS Growth
- PLRX N/A
- JVSA N/A
- EPS
- PLRX N/A
- JVSA 0.28
- Revenue
- PLRX N/A
- JVSA N/A
- Revenue This Year
- PLRX N/A
- JVSA N/A
- Revenue Next Year
- PLRX N/A
- JVSA N/A
- P/E Ratio
- PLRX N/A
- JVSA $39.13
- Revenue Growth
- PLRX N/A
- JVSA N/A
- 52 Week Low
- PLRX $1.10
- JVSA $10.09
- 52 Week High
- PLRX $16.52
- JVSA $10.78
- Technical
- Relative Strength Index (RSI)
- PLRX 41.87
- JVSA N/A
- Support Level
- PLRX $1.36
- JVSA N/A
- Resistance Level
- PLRX $1.72
- JVSA N/A
- Average True Range (ATR)
- PLRX 0.11
- JVSA 0.00
- MACD
- PLRX 0.04
- JVSA 0.00
- Stochastic Oscillator
- PLRX 29.17
- JVSA 0.00
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About JVSA JVSPAC ACQUISITION CORP
JVSPAC Acquisition Corp is blank check company.